FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-9.84 Cr | ₹-129 Cr |
What is the latest Cash Flow from Financing Activities ratio of FDC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-92 Cr |
| Mar2024 | ₹-202 Cr |
| Mar2023 | ₹-180 Cr |
| Mar2022 | ₹-9.84 Cr |
| Mar2021 | ₹-129 Cr |
How is Cash Flow from Financing Activities of FDC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-92 Cr | Negative | |
| Mar2024 | ₹-202 Cr | Negative | |
| Mar2023 | ₹-180 Cr | Negative | |
| Mar2022 | ₹-9.84 Cr | Negative | |
| Mar2021 | ₹-129 Cr | - | |
Compare Cash Flow from Financing Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,131.9 Cr | 1.2% | -10.3% | -18.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 1.2% |
-10.3% |
-18.5% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses